Validation of Etest for seven antimicrobial agents using regulatory criteria for the assessment of antimicrobial susceptibility devices

Diagnostic Microbiology and Infectious Disease

Volumn 27, Issue 1-2, 1997, Pages 1-5

  Biedenbach, Douglas J ^a   Schermer, Ian H ^a   Jones, Ronald N ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AZTREONAM; CEFDINIR; CEFPROZIL; CEFTAZIDIME; SPARFLOXACIN; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DEVICE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; QUALITY CONTROL;

AMIKACIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; AZTREONAM; CEFTAZIDIME; CEPHALOSPORINS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FLUOROQUINOLONES; MICROBIAL SENSITIVITY TESTS; MONOBACTAMS; PSEUDOMONAS AERUGINOSA; QUINOLONES; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; TOBRAMYCIN;

EID: 0030935294     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(96)00217-9     Document Type: Article

References (10)

1. Baker CN, Stocker SA, Culver DH, Thornsberry C (1991) Comparison of the Etest to agar dilution, broth-microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol 29:533-538.
2. Biedenbach DJ, Jones RN (1996) Comparative assessment of Etest for testing susceptibilities of Neisseria gonorrhoeae to penicillin, tetracycline, ceftriaxone, cefotaxime, and ciprofloxacin: Investigation using 510(k) review criteria, recommended by the Food and Drug Administration. J Clin Microbiol 34:3214-3217.
3. Briggs BM, Jones RN, Erwin ME, Barrett MS, Johnson DM (1991) In vitro activity evaluations of cefdinir (FK482, CI-983, PD 134393) a novel orally administered cephalosporin. Diagn Microbiol Infect Dis 14:425-434.
4. Brogden RN, Heel RC (1986) Aztreonam; A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 31:96-130.
5. Brown DFJ, Brown L (1991) Evaluation of the Etest, A novel method of quantifying antimicrobial activity. J Antimicrob Chemother 27:185-190.
6. Cohen MA, Yodet S, Talbot GH (1996) Sparfloxacin world-wide in vitro literature: Isolate data available through 1994. Diagn Microbiol Infect Dis 25:53-64.
7. Kessler RE, Fung-Tomc JC (1992) In vitro activity of cefprozil compared with other cephalosporins. Infect Med 9(suppl C):10-18.
8. National Committee for Clinical Laboratory Standards NCCLS) (1993) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard M7-A3. 3rd edition. Villanova, PA: NCCLS.
9. National Committee for Clinical Laboratory Standards NCCLS) (1995) Performance standards for antimicrobialsusceptibility testing, fifth information supplement:NCCLS document no. M100-S6. Villanova, PA: NCCLS.
10. Sanchez ML, Jones RN (1993) Etest, An antimicrobial susceptibility testing method with broad clinical and epidemiological application. Antimicrob Newslett 8:1-7.